RGEN

Repligen Stock Analysis

AI Rating

Neutral
  • Quality8/10
  • Growth 6/10
  • Value 1/10
Repligen sales and earnings growth
RGEN Growth
Good
  • Revenue Y/Y 16.36%
  • EPS Y/Y 289.13%
  • FCF Y/Y -35.49%
Repligen gross and profit margin trends
RGEN Profitability
Good
  • Gross margin 52.30%
  • EPS margin 6.60%
  • ROIC 5Y 6.95%
Repligen net debt vs free cash flow
RGEN Risk
Great
  • Debt / Equity 0.3
  • Debt / FCF 1.3
  • Interest coverage 3.9

Repligen stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗